Emergent BioSolutions Inc. recognized the U.S. House of Representatives for adding over-the-counter (OTC) naloxone to every AED location in its buildings. This initiative provides direct access to first responders and individuals who may encounter someone experiencing an opioid overdose.
The effort, led by Representative Buddy Carter (R-GA), highlights the importance of expanding access to potentially life-saving treatments. Emergent remains focused on increasing access, awareness, and availability of its NARCAN Nasal Spray 4 mg and KLOXXADO Nasal Spray 8 mg.
Emergent, as the leading U.S. supplier of nasal naloxone, believes the OTC availability of naloxone has contributed to the reduction in overdose deaths reported by the U.S. Centers for Disease Control and Prevention. Measures like this reinforce the importance of having life-saving naloxone readily available, as opioid overdoses can occur anytime, anywhere.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.